Autopsy report · NCT02952144
Post Approval Study of Lixelle for the Treament of Dialysis-Related Amyloidosis
Cause of deathOther
“Ongoing adjustments”
Life of this trial
- Registered 1 year 1 month after it had already started.
- Suspended: paused, and may or may not restart.
- 40 participants planned (an estimate, not an actual count).
Vital statistics
- Status
- Suspended
- Phase
- Na
- Sponsor
- Kaneka Medical America LLC
- Sponsor type
- Industry
- Conditions
- Dialysis Amyloidosis
- Interventions
- Lixelle® treatment
- Participants
- 40 (planned, not actual)
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.